REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/06/2025
Voltar para busca
Dado oficial do USPTO
PRIMEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
24/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
25/11/2016
Data de registro
23/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2020
Última transação
24/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
FI
Examinador
TURNER, JASON
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Primex Pharmaceuticals Oy
Representantes
Elizabeth A. Cominolli Markert & Cominolli PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalsmedical and veterinary preparations for the treatment or prevention of dentaldermatologicalcardiovascularhematologicalbonerespiratory systemnervous systemendocrinologicalcirculatorygastroenterologicalgenito-urinary and sexual diseases and disordersstomachdigestivehormonaldiabeticmuscularskeletal systemrheumaticimmune systemoncologicalocularalimentary tract and metabolic diseases and disordersexcluding preparations for treatment of acne and except for or in connection with the treatment of Parkinson and/or of the restless-legs-syndrome and except for the treatment of thrombotic or embolic vascular diseasesall aforementioned goods not containing prostaglandins; anaesthetics and medicinal preparations for use in anesthesiasanitary preparations for medical purposes excluding preparations for treatment of acne and except for or in connection with the treatment of Parkinson and/or of the restless-legs-syndrome; dietetic food and nutritional supplements adapted for medical useexcept for or in connection with the treatment of Parkinson and/or of the restless-legs-syndrome; dietetic food and substances adapted for and veterinary use; food for babies; dietary supplements for humans and animals; medical plastersmaterials for medical dressingspledgets
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/11/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/10/2020
FIMP
FINAL DISPOSITION PROCESSED
08/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/09/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
23/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2020
PUBO
PUBLISHED FOR OPPOSITION
07/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/03/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
29/08/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
25/10/2018
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
02/10/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
31/08/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
31/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/08/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/08/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/04/2018
ALIE
ASSIGNED TO LIE
04/04/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/11/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/11/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/09/2017
GNSL
LETTER OF SUSPENSION E-MAILED
26/09/2017
CNSL
SUSPENSION LETTER WRITTEN
26/09/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/09/2017
GNSL
LETTER OF SUSPENSION E-MAILED
21/09/2017
CNSL
SUSPENSION LETTER WRITTEN
21/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/08/2017
RFNT
REFUSAL PROCESSED BY IB
25/03/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/03/2017
RFRR
REFUSAL PROCESSED BY MPU
09/03/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2017
CNRT
NON-FINAL ACTION WRITTEN
08/03/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/03/2017
DOCK
ASSIGNED TO EXAMINER
03/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PRIMEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.